MODIFIED SHINE-DALGARNO SEQUENCES AND METHODS OF USE THEREOF
    1.
    发明公开
    MODIFIED SHINE-DALGARNO SEQUENCES AND METHODS OF USE THEREOF 审中-公开
    改进的Shine-Dalgarno序列及其使用方法

    公开(公告)号:EP1530634A2

    公开(公告)日:2005-05-18

    申请号:EP03761989.7

    申请日:2003-06-25

    CPC分类号: C12N15/70 C12N15/63

    摘要: Novel Shine-Dalgarno (ribosome binding site) sequences, vectors containing such sequences, and host cells transformed with these vectors are provided. Methods of use of such sequences, vectors, and host cells for the efficient production of proteins and fragments thereof in prokaryotic systems are also provided. In particular embodiments of the invention, compounds and methods for high efficiency production of soluble protein in prokaryotic systems are provided.

    NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT
    3.
    发明公开
    NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT 审中-公开
    NEUTROKINE-ALPHA和NEUTROKINE-ALPHA SPLICE变体

    公开(公告)号:EP1507793A2

    公开(公告)日:2005-02-23

    申请号:EP02786413.1

    申请日:2002-10-16

    摘要: The present invention relates to nucleic acid molecules encoding Neutrokine-alpha and/or Neutrokine-alphaSV polypeptides, including soluble forms of the extracellular domain. Neutrokine-alpha and/or Neutrokine-alphaSV polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to antibodies or portions thereof that specifically bind Neutrokine-alpha and/or Neutrokine-alphaSV and diagnostic and therapeutic methods using these antibodies. Also provided are diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders using the compositions of the invention.

    摘要翻译: 本发明涉及编码嗜中性因子-α和/或中性因子-αSV多肽的核酸分子,包括可溶形式的胞外域。 还提供了中性因子-α和/或中性因子-αSV多肽以及载体,宿主细胞和用于产生它们的重组方法。 本发明还涉及特异性结合中性因子-α和/或中性因子-αSV的抗体或其部分以及使用这些抗体的诊断和治疗方法。 还提供了用于检测免疫系统相关病症的诊断方法和使用本发明组合物治疗免疫系统相关病症的治疗方法。